181 related articles for article (PubMed ID: 35340835)
1. Mediastinal germ cell tumours: where we are and where we are going-a narrative review.
Marandino L; Vogl UM
Mediastinum; 2022; 6():7. PubMed ID: 35340835
[TBL] [Abstract][Full Text] [Related]
2. Genomic features of mediastinal germ cell tumors: a narrative review.
Ozgun G; Nichols C; Kollmannsberger C; Nappi L
Mediastinum; 2022; 6():34. PubMed ID: 36582975
[TBL] [Abstract][Full Text] [Related]
3. Analysis of prognostic factors and establishment of prognostic model for primary mediastinal germ cell tumors: a case controlled study.
Leng C; Cui Y; Mai Z; Chen R; Yuan J; Wang K; Wen J; Fu J; Liu Q
Int J Surg; 2023 Sep; 109(9):2574-2584. PubMed ID: 37222675
[TBL] [Abstract][Full Text] [Related]
4. Primary mediastinal germ cell tumours: real world experience in the low middle income (LMIC) setting.
Joel A; Mathew N; Andugala SS; Daniel S; Gnanamuthu BR; John AO; Georgy JT; Chacko RT; Irodi A; Yadav B; John S; Singh A
Ecancermedicalscience; 2021; 15():1186. PubMed ID: 33777179
[TBL] [Abstract][Full Text] [Related]
5. Primary Mediastinal Germ Cell Tumors: A Thorough Literature Review.
Ozgun G; Nappi L
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831022
[TBL] [Abstract][Full Text] [Related]
6. Primary mediastinal germ cell tumors - A retrospective analysis of >30 years of experience in a single institution.
Koizumi T; Kanda S; Nihonmatu R; Gomi D; Sekiguchi N; Noguchi T; Fukushima T; Kobayashi T; Yamamoto H; Takeda T
Thorac Cancer; 2021 Mar; 12(6):807-813. PubMed ID: 33502089
[TBL] [Abstract][Full Text] [Related]
7. Primary mediastinal germ cell tumors.
Rosti G; Secondino S; Necchi A; Fornarini G; Pedrazzoli P
Semin Oncol; 2019 Apr; 46(2):107-111. PubMed ID: 31076171
[TBL] [Abstract][Full Text] [Related]
8. A Study of Patients with Primary Mediastinal Germ Cell Tumors Treated Using Multimodal Therapy.
Tanaka Y; Okamura T; Nagai T; Kobayashi D; Kobayashi T; Akita H; Moritoki Y; Yasui T
Adv Urol; 2017; 2017():1404610. PubMed ID: 28634489
[TBL] [Abstract][Full Text] [Related]
9. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Single-Center Experience.
Wang L; Zhao J; An T; Wang Y; Zhuo M; Wu M; Wang Z; Li J; Yang X; Chen H; Zhong J
Front Oncol; 2020; 10():1137. PubMed ID: 32766147
[No Abstract] [Full Text] [Related]
11. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
12. Primary Mediastinal Germ Cell Tumors-The University of Western Ontario Experience.
Lavi A; Winquist E; Nair SM; Chin JL; Izawa J; Fernandes R; Ernst S; Power NE
Curr Oncol; 2020 Dec; 28(1):78-85. PubMed ID: 33704177
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604).
Cafferty FH; White JD; Shamash J; Hennig I; Stenning SP; Huddart RA;
Eur J Cancer; 2020 Mar; 127():139-149. PubMed ID: 32007714
[TBL] [Abstract][Full Text] [Related]
14. Bleomycin, etoposide and cisplatinum (BEP) chemotherapy for metastatic germ cell tumours: treatment outcomes at UKM medical centre, Malaysia.
Azrif M; Leong YK; Aslan NM; Fong KV; Ismail F
Asian Pac J Cancer Prev; 2012; 13(6):2467-71. PubMed ID: 22938405
[TBL] [Abstract][Full Text] [Related]
15. Extragonadal germ cell tumors: clinical presentation and management.
Albany C; Einhorn LH
Curr Opin Oncol; 2013 May; 25(3):261-5. PubMed ID: 23422328
[TBL] [Abstract][Full Text] [Related]
16. First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial.
Bokemeyer C; Schleucher N; Metzner B; Thomas M; Rick O; Schmoll HJ; Kollmannsberger C; Boehlke I; Kanz L; Hartmann JT
Br J Cancer; 2003 Jul; 89(1):29-35. PubMed ID: 12838296
[TBL] [Abstract][Full Text] [Related]
17. Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience.
Pectasides D; Aravantinos G; Visvikis A; Bakoyiannis C; Halikia A; Kalofonos C; Kosmidis P; Skarlos D; Fountzilas G
Oncology; 1999 Jul; 57(1):1-9. PubMed ID: 10394118
[TBL] [Abstract][Full Text] [Related]
18. Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study.
Kaye SB; Mead GM; Fossa S; Cullen M; deWit R; Bodrogi I; van Groeningen C; Sylvester R; Collette L; Stenning S; De Prijck L; Lallemand E; deMulder P
J Clin Oncol; 1998 Feb; 16(2):692-701. PubMed ID: 9469359
[TBL] [Abstract][Full Text] [Related]
19. Treatment in germ cell tumours: state of the art.
Tjan-Heijnen VC; Oosterhof GO; de Wit R; De Mulder PH
Eur J Surg Oncol; 1997 Apr; 23(2):110-7. PubMed ID: 9158183
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
